| Literature DB >> 35850673 |
Cunzhen Yang1, Zien Feng1, Kefang Lai2, Fang Yi3, Zhiyin Chen1, Dongting Xu1, Yuling Li1.
Abstract
BACKGROUND: Female patients with chronic cough are more likely to suffer from urinary incontinence (UI). However, there are few data in regard of risks related with UI in female adults with chronic cough.Entities:
Keywords: Chronic cough; Female; Risk factors; Urinary incontinence
Mesh:
Year: 2022 PMID: 35850673 PMCID: PMC9295435 DOI: 10.1186/s12890-022-02069-w
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.320
Fig. 1Flow chart. CRF, Case report form; UI, Urinary incontinence
Baseline demographic and clinical characteristics
| Total | Urinary incontinence | Without urinary incontinence (n = 349) | ||
|---|---|---|---|---|
| Age(years) | 45.94 ± 14.01 | 49.46 ± 13.33 | 42.39 ± 13.85 | < 0.001* |
| Cough duration (months) | 24(8–84) | 36(12–108) | 18(6–48) | < 0.001* |
| BMI (kg/m2) | 22.6 ± 3.3(n = 370) | 23.2 ± 3.5(n = 193) | 21.9 ± 3.0(n = 177) | < 0.001* |
| Daytime CSS | 3(2–4) | 3(2–4) | 3(2–3) | 0.001* |
| Nighttime CSS | 2(1–2) | 2(1–3) | 2(1–2) | 0.001* |
| Cough VAS | 60(50–80) | 65(50–80) | 50(40–70) | < 0.001* |
| Dry cough, % | 52.2(360/690) | 51.7(180/349) | 52.6(180/342) | 0.811 |
| A single cough, % | 25.6(156/609) | 21.0(66/315) | 30.6(90/294) | 0.006* |
| Continuous cough, % | 69.7(435/624) | 70.4(226/321) | 69(209/303) | 0.698 |
| Seasonal, % | 29.8(200/671) | 31.6(108/342) | 28.0(92/329) | 0.306 |
| Timing of cough | ||||
| Daytime, % | 85.0(590/694) | 87.6(305/348) | 82.4(285/346) | 0.052 |
| Before sleep, % | 60.8(421/692) | 65.7(228/347) | 55.9(193/345) | 0.009* |
| Night, % | 52.6(364/692) | 57.6(200/347) | 47.5(164/345) | 0.008* |
| Morning, % | 46.4(321/692) | 49.3(171/347) | 43.5(150/345) | 0.126 |
| Triggers | ||||
| Dust, % | 51.2(354/691) | 57.3(199/347) | 45.1(155/344) | 0.001* |
| Cooking fume, % | 56.4(390/692) | 62.8(218/347) | 49.9(172/345) | 0.001* |
| Cold air, % | 54.3(375/691) | 58.7(203/346) | 49.9(172/345) | 0.020* |
| Common cold, % | 59.3(412/693) | 62.2(216/347) | 56.6(196/346) | 0.133 |
| Supine position, % | 23.6(163/690) | 29.4(102/347) | 17.8(61/343) | < 0.001* |
| Cigarette smoke, % | 55.3(383/693) | 63.2(220/348) | 47.2(163/345) | < 0.001* |
| Exercise, % | 20.2(139/689) | 23.2(80/345) | 17.2(59/344) | 0.048* |
| Talking, % | 37.6(260/692) | 39.9(138/346) | 35.3(122/346) | 0.209 |
| Alcohol, % | 2.9(17/594) | 2.9(9/306) | 2.8(8/288) | 0.905 |
| History of medication | ||||
| Oral corticosteroids, % | 19.9(112/563) | 22.8(66/289) | 16.8(46/274) | 0.072 |
| Inhaled corticosteroids, % | 34.6(197/570) | 37.5(110/293) | 31.4(87/277) | 0.124 |
| Antitussive drugs, % | 74.6(447/599) | 75.8(229/302) | 73.4(218/297) | 0.495 |
| Concomitant symptoms | ||||
| Sneezing, % | 36.7(256/697) | 38.6(135/350) | 34.9(121/347) | 0.311 |
| Rhinocnesmus, % | 25.8(179/694) | 28.0(91/347) | 23.6(82/347) | 0.193 |
| Nasal congestion, % | 28.1(195/693) | 28.7(100/348) | 27.5(95/345) | 0.726 |
| Postnasal dripping, % | 23.6(164/694) | 25.3(88/348) | 22.0(76/346) | 0.303 |
| Chest tightness, % | 31.2(216/693) | 35.0(122/349) | 27.3(94/344) | 0.030* |
| Shortness of breath, % | 22.8(158/693) | 25.9(90/348) | 19.7(68/345) | 0.054 |
| Acid regurgitation, % | 19.3(134/696) | 20.9(73/350) | 17.6(61/346) | 0.280 |
| Nausea, % | 20.4(142/696) | 22.0(77/350) | 18.8(65/346) | 0.293 |
| Belching, % | 21.4(149/695) | 22.6(79/349) | 20.2(70/346) | 0.440 |
| Heartburn, % | 8.2(57/694) | 10.0(35/349) | 6.4(22/345) | 0.080 |
| Upper abdominal pain, % | 8.8(61/696) | 11.4(40/350) | 6.1(21/346) | 0.012* |
| Throat clearing, % | 34.9(242/693) | 38.2(133/348) | 31.6(109/345) | 0.067 |
| Itchy throat, % | 60.4(420/695) | 64.3(225/350) | 56.5(195/345) | 0.036* |
| Itching below the throat, % | 29.9(209/698) | 28.3(99/350) | 31.6(110/348) | 0.338 |
Pharyngeal foreign body sensation, % | 34.1(221/649) | 38.2(128/335) | 29.6(93/314) | 0.021* |
| Abdominal muscle pain due to cough, % | 29.2(204/699) | 39.6(139/351) | 18.7(65/348) | < 0.001* |
| Comorbidities | ||||
| Gastrointestinal disorders, % | 24.4(164/672) | 24.7(83/336) | 24.2(81/336) | 0.857 |
| Hypertension, % | 14.9(100/670) | 19.5(65/334) | 10.4(35/336) | 0.001* |
| Allergic rhinitis, % | 25.3(170/672) | 22.6(76/336) | 28.0(94/336) | 0.110 |
| Chronic sinusitis, % | 12.6(85/672) | 17.6(59/336) | 8.6(29/336) | 0.002* |
Data presented as mean ± SD or median (IQR) or percentage (positive cases/ total cases in groups except for missing value). Patients with UI vs patients without UI
*p < 0.05
UI Urinary incontinence, CSS Cough symptom score, VAS Visual analogue scale, OCS Oral corticosteroids, ICS Inhaled corticosteroids
Fig. 2A Etiological distribution in patients with UI and patients without UI. B Proportion of single etiology and compound etiology between patients with and without UI. UI, Urinary incontinence; EB, Eosinophilic bronchitis; GERC, Gastroesophageal reflux cough; UACS, Upper airway cough syndrome; AC, Atopic cough; UC, Unexplained chronic cough; CRC, Chronic refractory cough
Relationship between urinary incontinence and age or BMI of different grades
| Occurrence rate% (95% | Cases in group UI (%) | Cases in group without UI (%) | Univariate analysis | ||
|---|---|---|---|---|---|
| Age(years) | 50.1 (46.4–53.9) | 351 (50.1%) | 349 (49.9%) | < 0.001 | |
| 18–30 | 26.2 (17.7–34.6) | 28 (8.0%) | 79 (22.6%) | 1 | |
| 31–40 | 42.0 (34.5–49.4) | 73 (20.8%) | 101 (28.9%) | 2.039 (1.205–3.450) | 0.008 |
| 41–50 | 59.1 (51.1–67.0) | 88 (25.1%) | 61 (17.5%) | 4.070 (2.370–6.990) | < 0.001 |
| 51–60 | 57.5 (49.6–65.4) | 88 (25.1%) | 65 (18.6%) | 3.820 (2.232–6.536) | < 0.001 |
| > 60 | 63.2 (54.4–72.1) | 74 (21.1%) | 43 (12.3) | 4.855 (2.741–8.602) | < 0.001 |
| BMI (kg/m2) | 52.2 (47.0–57.3) | 193 (52.2%) | 177 (47.8%) | 0.008 | |
| Underweight (< 18.5) | 39.4 (21.8–57.0) | 13 (6.7%) | 20 (11.3%) | 0.710 (0.337–1.495) | 0.367 |
| Normal (18.5–23.9) | 47.8 (41.3–54.3) | 109 (56.5%) | 119 (67.2%) | 1 | |
| Overweight (24–27.9) | 62.8 (52.4–73.2) | 54 (28.0%) | 32 (18.1%) | 1.842(1.108–3.064) | 0.019 |
| Obesity (≥ 28) | 73.9 (54.5–93.3) | 17 (8.8%) | 6 (3.4%) | 3.093 (1.177–8.130) | 0.022 |
CI, Confidence interval; BMI, Body mass index; UI, Urinary incontinence
Multivariate logistic regression analysis on risk factors of UI in female patients with chronic cough
| Multivariate analysis | |||
|---|---|---|---|
| 95% CI | |||
| Age(years) | < 0.001 | ||
| I 18–30 | 1 | ||
| II 31–40 | 2.087 | 1.022–4.264 | 0.043 |
| III 41–50 | 3.801 | 1.798–8.036 | < 0.001 |
| IV 51–60 | 2.981 | 1.440–6.171 | 0.003 |
| V > 60 | 5.471 | 2.455–11.954 | < 0.001 |
| Cough VAS | 1.027 | 1.016–1.038 | < 0.001 |
| Combining with chronic sinusitis | 1.918 | 1.026–3.588 | 0.041 |
| Cough triggered by exercise | 1.736 | 1.036–2.907 | 0.036 |
Abdominal muscle pain due to cough | 3.167 | 1.931–5.194 | < 0.001 |
VAS, Visual analogue scale; CI, Confidence interval